By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pharmatech, Inc. 

789 Sherman Street
Suite 600
Denver  Colorado  80203  U.S.A.
Phone: Fax:


Company News
Actavis (ACT) To Divest Pharmatech, Inc. To TPG 2/13/2015 7:31:34 AM
Pharmatech, Inc. To Revolutionize Clinical Grants To Research Centers 12/8/2014 10:53:21 AM
Pharmatech, Inc. Release: Pharmatech Precision Medicine Research System (AccessPPM) Takes Aim At Lung Cancer 10/28/2014 10:42:14 AM
Pharmatech, Inc. Announces Research Collaboration Under Phase II National Cancer Institute/SBIR Grant With Weill Cornell Medical College 9/8/2014 9:44:18 AM
Paradigm Initiates Genomic Profiling For Pharmatech, Inc.'s AccessPPM Cancer Registry Program 8/5/2014 6:25:12 AM
PharmAthene, Inc. (PIP) Presents New SparVax┬« Anthrax Vaccine Data At The American Society for Microbiology 2014 Meeting 5/29/2014 10:55:26 AM
Pharmatech, Inc. Launches New Solid Dose Division 1/13/2009 9:31:52 AM
Pharmatech, Inc. Introduces Pharmatech Oncology 1/5/2009 6:50:14 AM
Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials New JIT Enrollment Program Speeds Oncology Patient Accrual 7/25/2008 7:30:24 AM
Pharmatech, Inc. Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial 3/3/2008 9:46:45 AM